Literature DB >> 8062194

Low grade transitional cell carcinoma of the bladder. Cytologic diagnosis by key features as identified by logistic regression analysis.

S S Raab1, J C Lenel, M B Cohen.   

Abstract

BACKGROUND: Bladder cytology is being used increasingly to detect and monitor early stage bladder cancer. Because of the lack of significant cytomorphologic atypia in low grade transitional cell carcinomas (TCCs), there often is great difficulty in separating these neoplastic cells from benign urothelial cells.
METHODS: In an attempt to increase diagnostic sensitivity, 82 bladder wash specimens, which included 33 low grade TCCs and 49 nonneoplastic lesions, were reviewed retrospectively. With a stepwise logistic regression analysis, three key cytomorphologic criteria useful in the separation of low grade TCC from benign urothelium were identified.
RESULTS: The key cytologic criteria were increased nuclear/cytoplasmic ratios, irregular nuclear borders, and cytoplasmic homogeneity. By using contingency tables, these three criteria combined had a sensitivity of 45% and a specificity of 98% in the diagnosis of low grade transitional cell carcinoma. If any two of the criteria were present, there was a sensitivity of 85% and a specificity of 96%.
CONCLUSIONS: By using these three criteria, the diagnosis of TCC can be made with a high degree of accuracy in bladder wash specimens.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8062194     DOI: 10.1002/1097-0142(19940901)74:5<1621::aid-cncr2820740521>3.0.co;2-e

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  17 in total

1.  Detection of hyaluronidase RNA and activity in urine of schistosomal and non-schistosomal bladder cancer.

Authors:  Sanaa Eissa; Hanan Shehata; Amal Mansour; Mohamed Esmat; Omar El-Ahmady
Journal:  Med Oncol       Date:  2012-07-04       Impact factor: 3.064

2.  Accuracy of grading of urothelial carcinoma on urine cytology: an analysis of interobserver and intraobserver agreement.

Authors:  Michelle D Reid; Adeboye O Osunkoya; Momin T Siddiqui; Stephen W Looney
Journal:  Int J Clin Exp Pathol       Date:  2012-10-20

3.  Cytological and morphometric study of urinary epithelial cells with histopathological correlation.

Authors:  Asim Kumar Manna; Manisha Sarkar; Ujjal Bandyopadhyay; Srabani Chakrabarti; Swapan Pathak; Diptendra Kumar Sarkar
Journal:  Indian J Surg       Date:  2012-06-16       Impact factor: 0.656

4.  Telomerase activity detected by quantitative assay in bladder carcinoma and exfoliated cells in urine.

Authors:  R Fedriga; R Gunelli; O Nanni; F Bacci; D Amadori; D Calistri
Journal:  Neoplasia       Date:  2001 Sep-Oct       Impact factor: 5.715

Review 5.  Applications of telomerase in urologic oncology.

Authors:  J Landman; E Kavaler; M J Droller; B C Liu
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

6.  Evaluation of acridine orange fluorescence in exfoliative urinary cytology for diagnosing bladder carcinoma.

Authors:  Ranlu Liu; Zhentao Tian; Jin Wang; Zhihong Zhang; Yong Xu
Journal:  Int Urol Nephrol       Date:  2012-04-21       Impact factor: 2.370

7.  The clinical relevance of urine-based markers for diagnosis of bladder cancer.

Authors:  Sanaa Eissa; Menha Swellam; Amr Amin; Mohamed E Balbaa; Galila Ahmed Yacout; Tarek Mostafa El-Zayat
Journal:  Med Oncol       Date:  2011-03-25       Impact factor: 3.064

8.  Diagnostic significance of atypical category in the voided urine samples: A retrospective study in a tertiary care center.

Authors:  Ghadeer A Mokhtar; Mohamed Al-Dousari; Doaa Al-Ghamedi
Journal:  Urol Ann       Date:  2010-09

9.  CK20 and Ki-67 as significant prognostic factors in human bladder carcinoma.

Authors:  Yong-kang Ye; Xue-cheng Bi; Hui-chan He; Zhao-dong Han; Qi-shan Dai; Yu-xiang Liang; Guo-hua Zeng; Wei-jun Qin; Zhi-nan Chen; Wei-de Zhong
Journal:  Clin Exp Med       Date:  2010-01-13       Impact factor: 3.984

10.  Urine telomerase: an important marker in the diagnosis of bladder cancer.

Authors:  Maria Aurora Sanchini; Sara Bravaccini; Laura Medri; Roberta Gunelli; Oriana Nanni; Franco Monti; Paolo Carlo Baccarani; Alberto Ravaioli; Eduard Bercovich; Dino Amadori; Daniele Calistri
Journal:  Neoplasia       Date:  2004 May-Jun       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.